Henry Schein (NASDAQ:HSIC) Issues FY 2024 Earnings Guidance

Henry Schein (NASDAQ:HSIC) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 4.740-4.820 for the period, compared to the consensus earnings per share estimate of 4.750. The company issued revenue guidance of $12.8 billion-$13.0 billion, compared to the consensus revenue estimate of $12.9 billion.

Wall Street Analysts Forecast Growth

HSIC has been the subject of a number of recent research reports. JPMorgan Chase & Co. cut their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. Barrington Research reissued an “outperform” rating and set a $82.00 price target on shares of Henry Schein in a report on Wednesday. UBS Group reduced their price target on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. Robert W. Baird lowered their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. Finally, Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. One analyst has rated the stock with a sell rating, six have assigned a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Henry Schein presently has a consensus rating of “Hold” and a consensus target price of $77.50.

Henry Schein Price Performance

Shares of HSIC stock opened at $69.43 on Friday. The stock has a 50 day moving average price of $70.56 and a 200 day moving average price of $69.78. Henry Schein has a 52-week low of $62.12 and a 52-week high of $82.63. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.55. The firm has a market capitalization of $8.80 billion, a P/E ratio of 25.71, a P/E/G ratio of 2.08 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The company had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The firm’s revenue for the quarter was up .4% on a year-over-year basis. During the same quarter last year, the business posted $1.32 EPS. As a group, sell-side analysts predict that Henry Schein will post 4.74 earnings per share for the current year.

Insiders Place Their Bets

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the transaction, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.14% of the stock is owned by company insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.